WallStSmart

CME Group Inc (CME)vsTransUnion (TRU)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

CME Group Inc generates 43% more annual revenue ($6.74B vs $4.73B). CME leads profitability with a 63.3% profit margin vs 14.9%. TRU appears more attractively valued with a PEG of 1.06. TRU earns a higher WallStSmart Score of 72/100 (B).

CME

Buy

65

out of 100

Grade: C+

Growth: 6.7Profit: 8.0Value: 4.3Quality: 5.0
Piotroski: 2/9Altman Z: 0.30

TRU

Strong Buy

72

out of 100

Grade: B

Growth: 7.3Profit: 6.5Value: 5.7Quality: 6.0
Piotroski: 6/9Altman Z: 1.52

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CME6 strengths · Avg: 9.0/10
Profit MarginProfitability
63.3%10/10

Keeps 63 of every $100 in revenue as profit

Operating MarginProfitability
69.8%10/10

Strong operational efficiency at 69.8%

Market CapQuality
$90.52B9/10

Large-cap with strong market position

Debt/EquityHealth
0.139/10

Conservative balance sheet, low leverage

EPS GrowthGrowth
21.3%8/10

Earnings expanding 21.3% YoY

Free Cash FlowQuality
$1.24B8/10

Generating 1.2B in free cash flow

TRU1 strengths · Avg: 10.0/10
EPS GrowthGrowth
172.0%10/10

Earnings expanding 172.0% YoY

Areas to Watch

CME3 concerns · Avg: 2.3/10
Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

PEG RatioValuation
4.522/10

Expensive relative to growth rate

Altman Z-ScoreHealth
0.302/10

Distress zone — elevated risk

TRU2 concerns · Avg: 3.5/10
Altman Z-ScoreHealth
1.524/10

Distress zone — elevated risk

Debt/EquityHealth
1.203/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : CME

The strongest argument for CME centers on Profit Margin, Operating Margin, Market Cap. Profitability is solid with margins at 63.3% and operating margin at 69.8%. Revenue growth of 14.4% demonstrates continued momentum.

Bull Case : TRU

The strongest argument for TRU centers on EPS Growth. Revenue growth of 13.7% demonstrates continued momentum. PEG of 1.06 suggests the stock is reasonably priced for its growth.

Bear Case : CME

The primary concerns for CME are Piotroski F-Score, PEG Ratio, Altman Z-Score.

Bear Case : TRU

The primary concerns for TRU are Altman Z-Score, Debt/Equity.

Key Dynamics to Monitor

CME profiles as a mature stock while TRU is a value play — different risk/reward profiles.

TRU carries more volatility with a beta of 1.55 — expect wider price swings.

CME is growing revenue faster at 14.4% — sustainability is the question.

CME generates stronger free cash flow (1.2B), providing more financial flexibility.

Bottom Line

TRU scores higher overall (72/100 vs 65/100) and 13.7% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

CME Group Inc

FINANCIAL SERVICES · FINANCIAL DATA & STOCK EXCHANGES · USA

CME Group Inc. (Chicago Mercantile Exchange, Chicago Board of Trade, New York Mercantile Exchange, The Commodity Exchange) is an American global markets company. It is the world's largest financial derivatives exchange, and trades in asset classes that include agricultural products, currencies, energy, interest rates, metals, stock indexes and cryptocurrencies futures.

Visit Website →

TransUnion

FINANCIAL SERVICES · FINANCIAL DATA & STOCK EXCHANGES · USA

TransUnion offers risk and information solutions. The company is headquartered in Chicago, Illinois.

Visit Website →

Want to dig deeper into these stocks?